Fosaprepitant dimeglumine is a prodrug belonging to the neurokinin-1 (NK-1) receptor antagonist class, clinically utilized as an intravenously administered antiemetic to prevent nausea and vomiting associated… Read more



Fosaprepitant dimeglumine is a prodrug belonging to the neurokinin-1 (NK-1) receptor antagonist class, clinically utilized as an intravenously administered antiemetic to prevent nausea and vomiting associated with chemotherapy. As a prodrug of aprepitant, its accurate analysis is critical in pharmaceutical development and manufacturing. This category encompasses a comprehensive collection of reference standards, including the active pharmaceutical ingredient, its structural impurities, enantiomers, and degradation products, alongside relevant stable isotope labelled compounds. Pharmaceutical laboratories rely on these high-quality materials for precise impurity profiling, method validation, and routine quality control testing. By providing consistent and reliable standards for both pharmacopeial and non-pharmacopeial impurities, these compounds ensure that analytical methods remain robust and compliant with strict regulatory requirements throughout the drug development lifecycle.